Scientists reveal a new mechanism that increases atherosclerosis in mice

For all the good it does, a liver protein that senses and gets rid of drugs and pollutants from our body has a downside. For the first time, it has been shown that when it is chronically activated, the protein, called PXR, rejiggers how cholesterol is processed in the liver and increases the risk of developing atherosclerosis. The work has direct clinical consequences to patients under long-term treatment of PXR-activating drugs, including several antibiotic and anti-cancer medications — and your daily latte.

Read the original post:
Scientists reveal a new mechanism that increases atherosclerosis in mice

Tags: a-liver-protein, antibiotic-and, biomedicine, good-it-does, patients-under

Related posts:

1. High fat diet increases inflammation in the mouse colon
2. Elusive protein points to mechanism behind hearing loss
3. The development of hepatic fibrosis occurs normally in AMPK deficient mice
4. Hypoxia aggravates nonalcoholic steatohepatitis in mice lacking hepatocellular PTEN
5. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE -/- mice

Related posts brought to you by Yet Another Related Posts Plugin.

• Previous Entry: Immune system uses a “leash” to restrict HIV’s spread
• Next Entry: Clopidogrel application: beyond coronary artery disease